DocumentCode
2170883
Title
Future of simulation in biotechnology industry
Author
Saraph, Prasad V.
Author_Institution
Bayer Healthcare - Biol. Products, Berkeley, CA, USA
Volume
2
fYear
2004
fDate
5-8 Dec. 2004
Firstpage
2052
Abstract
In the 21st century, the biotechnology industry has the potential to inspire a number of management tools and theories, just as the automobile industry did in the 20th century. This paper explores the opportunities for simulation in biotechnology over the next few years and provides structure for the panel discussion in biotechnology and health care track. We detail the structure for biotechnology industry, review status and opportunities for simulation and present gap analysis of opportunities and tools available. The purpose of the panel discussion is to discuss the role for simulation community in biotechnology industry over the next few years and identify key areas where simulation can add value.
Keywords
biotechnology; digital simulation; technological forecasting; biotechnology industry; biotechnology simulation; health care; simulation community; Analytical models; Biological system modeling; Biotechnology; Clinical trials; Drugs; Humans; Manufacturing industries; Marketing and sales; Marketing management; Production systems;
fLanguage
English
Publisher
ieee
Conference_Titel
Simulation Conference, 2004. Proceedings of the 2004 Winter
Print_ISBN
0-7803-8786-4
Type
conf
DOI
10.1109/WSC.2004.1371569
Filename
1371569
Link To Document